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Accurate mass spectrometrySludge from sewage treatment plants (STPs) is recognized as a sink of moderate to high lipophilic compounds
resistant to biodegradation. Herein, we investigate the presence of emerging pollutants in sewage sludge com-
bining the information providedbymass spectrometry detection, following ultra-performance liquid chromatog-
raphy (UPLC), with the use of an accurate spectral database of pesticides and pharmaceuticals. In a first step, the
performance of matrix solid-phase dispersion, as sample preparation technique, and two non-target data acqui-
sition strategies (data dependent, DDA, and data independent analysis modes, DIA), used in combination with a
UPLC quadrupole time-of-flight system, are assessed using a selection of deuterated compounds added either to
freeze-dried sludge samples, or to sludge extracts. Possibilities and limitations of both modes are discussed. Fol-
lowing the DDA approach, a group of 68 micropollutants was identified in sludge from different STPs. Some of
them are reported in this compartment for the first time. Finally, semi-quantitative concentration data are re-
ported for a group of 37 pollutants in samples obtained from 16 STPs. Out of them, 10 pharmaceuticals, showing
detection frequencies and median sludge residues above 50% and 100 ng g−1, respectively; are highlighted as
pollutants to be monitored in sludge in order to understand their behaviour during the wastewater treatment.
© 2021 Elsevier B.V. All rights reserved.1. Introduction
A large number of pharmaceuticals and personal care products
(PPCPs), pesticides, household cleaning products, and other substances
employed in different industrial processes, are used in developed
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source and route of entry of these chemicals into the aquatic environ-
ment, mainly due to their inefficient removal at sewage treatment
plants (STPs) (Blum et al., 2018). Thus, the continuous release of these
compounds in the aquatic media might constitute a potential risk to
humans and ecosystems (Gavrilescu et al., 2015; Nika et al., 2020; Wu
et al., 2019). Although the levels of pollutants in wastewater have
been deeply studied during the last decade (Deblonde et al., 2011;
Stuart et al., 2012), the potential accumulation of these compounds in
sewage sludge remains mostly unexplored. Moreover, most efforts
have been focused on the study of a preselected number of compounds,
or family of compounds (Ivanová et al., 2018; Li et al., 2016; Martín-
Pozo et al., 2019).
Sludge is a complex matrix, whose heterogeneous composition de-
pends on the nature of the inputs at STPs (Hörsing et al., 2011). The
presence of a large number of compounds in sludge extracts at different
concentrations (from low ng g−1 to several μg g−1), makes the study of
these samples a real challenge (Martín-Pozo et al., 2019). Regarding the
fact that this residue contains a wide variety of organic and inorganic
substances (Svahn and Björklund, 2015), and that sludge from STPs is
often re-used as agricultural fertilizer, and as raw material in compost
(Christodoulou and Stamatelatou, 2016), the characterization of
micropollutants existing in these samples, and the approach of new
screening analysis strategies are highly recommended. Identification
and quantification of micropollutants in sludge samples is also a basic
requirement to obtain a global picture of their behaviour duringmunic-
ipalwater treatments, comparing concentrationsmeasured in the aque-
ous phase with those existing in sludge.
Some recent studies have summarized the analytical methodologies
applied to the determination of emerging pollutants in sludge during
the last years (Martín-Pozo et al., 2019; Pérez-Lemus et al., 2019). On
theonehand, in target analysis, where the analytes are pre-selected, liq-
uid chromatography coupled to triple quadrupole (QqQ) mass spec-
trometers, working in MRM mode, leads to high selectivity and
extremely low quantification limits. However, this strategy covers
only the set of pre-defined compounds and is totally blind to any
other species present in the sample (Gago-Ferrero et al., 2015; Petrie
et al., 2016). On the other hand, non-target screening analysis requires
the use of high resolution/accurate mass spectrometry (HRMS), either
based on the use of time-of-flight (TOF) or Orbitrap mass analyzers,
where accurate spectral records in SCAN mode, throughout the entire
chromatographic separation process, are obtained. Thus, the
combination of HRMSwithmild ionization sources, such as electrospray
ionization (ESI), allows recording the accurate m/z ratios for pseudo-
molecular ions (usually, [M + H]+ or [M-H]−) of any species existing
in the sample, which survives the sample preparation and ionization
steps (Krauss et al., 2010). This latent information offers the possibility
of detecting new pollutants in environmental matrices and it results
very attractive for the search of new pollutants in complex matrices
such as sludge (Castro et al., 2016; Veenaas et al., 2018).
The most common operational modes of HRMS systems for non-
target screening studies are termed as data dependent (DDA) and data
independent (DIA) acquisition modes, (Ccanccapa-cartagena et al.,
2019;Martínez-Bueno et al., 2019;Moschet et al., 2017). DDA combines
accurate MS scan spectra with authentic product ion spectra for an au-
tomated selection of precursor ions isolated by the first MS analyzer
(usually a quadrupole). DIA does not provides real MS/MS spectra; in-
stead, pseudo-MS/MS scan spectra are recorded, applying different col-
lision energies to the range of ions generated in the ionization source
from those molecules with the same retention time in the LC column;
then, all ions (primary features and their fragments) are directed to
the accurate MS analyzer (i.e., TOF). In both cases, the mining of raw
data is an intensive task, whose success depends on the existence of ap-
propriate spectral databases of accurate MS and MS/MS spectra. What-
ever the data acquisition mode, the quality of MS and MS/MS spectra
(mass accuracy and purity of the isotopic profile for the2
pseudo-molecular ions and product ions) is a key issue to guarantee
the proper identification of a database compound in the extract from a
complex matrix, as it is the case of sludge samples, with a high percent-
age of organic matter, corresponding to natural and man-made
chemicals.
In this research, the range of possibilities offered by QTOF-MS sys-
tems, for the non-target screening of unknown species, are investigated
for the particular case of sewage sludge samples. To that aim, matrix-
solid phase dispersion (MSPD)wasfirst applied to the non-selective ex-
traction of organic compounds existing in sludge samples. Extractswere
processed by UPLC-QTOF-MS using reversed-phase separation condi-
tions. Thereafter, acquisition and data mining strategies, based on DDA
and DIA analysis, were compared for the identification of a selection of
deuterated compounds spiked to sludge at different concentration
levels. After choosing the data acquisitionmode, the presence of emerg-
ing pollutants was screened in different sludge samples. Additionally,
semi-quantitative concentration data, estimated using matrix-
matched standards prepared with spiked extracts obtained from a
pool of sludge samples, are provided for a selection of 37 compounds.
2. Material and methods
2.1. Material, solvents and standards
Polypropylene syringes (12 mL volume) and polyethylene frits for
MSPDextraction (20 μm, 15mL)were supplied by International Sorbent
Technology (Mid Glamorgan, UK). The dispersant sorbent (C18-bonded
silica) was purchased from Agilent Technologies (Santa Clara, CA, USA).
Diatomaceous earth, used as co-sorbent, was obtained from Sigma-
Aldrich (Milwaukee, WI, USA).
Methanol (MeOH), HPLC-grade, and formic acid (FA) were pur-
chased from Merck (Darmstadt, Germany). Ultrapure water (18.2 mΩ
cm−1) was obtained from a Milli-Q system by Millipore (Billerica,
MA, USA).
Standards of tentatively identified compounds in the extracts from
sludge samples, were acquired from Sigma-Aldrich and TCI Europe
(Zwijndrecht, Belgium). Deuterated compounds, either used as surrogate
standards (SS) through sample preparation, or asmodel species during as-
sessment of data acquisition approaches: clotrimazole-d5 (CTZ-d5),
amiodarone-d4 (AMI-d4), irbesartan-d4 (IRB-d4), miconazole-d5 (MCZ-
d5) and itraconazole-d5 (ITZ-d5) were supplied by Toronto Research
Chemicals (North York, ON, Canada), whereas imazalil-d5 (IMZ-d5) and
sertraline-d3 (SER-d3) were purchased from Sigma-Aldrich. Individual
stock solutions of each compound were prepared in MeOH. Further dilu-
tions were made in the same solvent.
2.2. Samples and sample preparation
Grab sludge samples were obtained from municipal STPs located in
Galicia (Northwest of Spain) during 2018. Fig. S1 shows the geographic
situation of STPs. After reception, samples were lyophilized and stored
in glass vessels at 4 °C. Sample preparation was based on a generic
MSPD extraction procedure (Celano et al., 2014). In brief, a fraction of
0.5 g of lyophilized sludge, spiked with 1 μg g−1 of the mixture of SSs,
was dispersed using 2 g of C18 in a glass mortar, for 5 min. The blend
was loaded into a polypropylene syringe containing a polyethylene frit
and 1 g of diatomaceous earth. A second frit was placed on the top to
compact the cartridge. Compounds were extracted passing MeOH
through the MSPD cartridge, collecting an extract volume of 10 mL.
This extract was filteredwith a PTFE filter, 0.2 μmpore size, and injected
in the UPLC-QTOF-MS system without any additional treatment.
Spiked samples, employed to evaluate the efficiency of theMSPD ex-
traction, were prepared by addition of methanolic mixtures of 42 se-
lected drugs to a pool of freeze-dried sludge samples (addition level
1 μg g−1). Procedural blanks (without any sludge in the MSPD packed
syringe) were prepared every 5 samples in order to investigate possible
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sample preparation experiments, the yield of MSPD extraction and the
performance of data acquisition and data mining strategies were evalu-
ated using sludge samples spiked with the mixture of deuterated com-
pounds reported in section 2.1.
2.3. Equipment and software
The screening and determination of emerging pollutants residues in
sludge extracts were performed in a UPLC-QTOF-MS system. The chro-
matograph was an Agilent 1290 Series (Wilmington, DE, USA),
consisting of a binary high-pressure mixing pump, oven and
autosampler. The QTOF was an Agilent 6550 model, equipped with a
Dual-Spray ESI source, which used nitrogen (99.999%) for nebulization
(30 psi) and drying gas (200 °C, 12 L min−1). Nitrogen was also
employed as sheath gas (12 L min−1, 350 °C). Capillary, nozzle and
fragmentor voltageswere set at 3500, 0 and 170 V, respectively. Regard-
ing the QTOF hybrid analyzer, it worked in 2 GHz Extended Dynamic
Range resolution mode (mass resolution 10,000 at m/z value of
118.0862). Considering that molecules of most of the prescribed drugs
contain basic moieties, the ESI source was operated in the positive
mode (ESI+) throughout the current study. Recalibration of the
mass axiswas continuously performed considering ionswithm/z values
of 121.0509 (purine) and 922.0098 (hexakis(1H, 1H, 3H-
tetrafluoropropoxy) phosphazine).
LC separations were performed in a Zorbax Eclipse Plus C18 Rapid
Resolution HD column (2.1 × 50 mm, 1.8 μm) acquired from Agilent
Technologies. The analytical column was connected to a C18 2.1 mm i.
d. Security Guard™ ultra-cartridge supplied by Phenomenex (Torrance,
CA, USA). Mobile phases were ultrapure water (A) and MeOH (B), both
containing 0.1% FA, at a constantflow rate of 0.4mLmin−1. The gradient
was programmed as follow: 0–0.5 min, 20% B; 6–7 min, 100% B;
7.1–10 min, 20% B. Column and pre-column were maintained at 40 °C.
The injected volume for solvent standards and sample extracts was 1 μL.
MassHunter software package (Agilent Technologies) was used to
control the acquisition parameters of the UPLC-QTOF-MS instrument,
in the different operational modes, as well as for processing the ob-
tained data.MassHunter Qualitative software (version B.08.00), in com-
bination with a PCDL library (ForTox PCDL database from Agilent
Technologies, containing above 9000 compounds), was applied during
data mining from raw LC-MS records acquired following DDA or DIA
modes. The ForTox database was completed with the product ion spec-
tra of isotopically labelled species involved in the current research.
Spectra were acquired at collision energies of 10, 20 and 40 eV, from
[M + H]+ ions of deuterated compounds, except in case of CTZ-d5,
(product ion spectra acquired from [M-C3H3N2]+).
2.4. UPLC-HRMS screening of emerging pollutants
2.4.1. DIA analysis
DIA (also known as all ions, or MSE acquisition mode) spectra were
recorded in the range ofm/z values from50 to 1000, at a rate of 4 spectra
s−1. In addition toMS spectra, three acquisition functions, with different
collision energies (10, 20 and 40 eV), were used with the aim to obtain
as much information as possible for compounds ionized in the ESI
source. Data mining was developed using a target/suspect screening
workflow, Find by formula tool (with fragment confirmation), which
uses the input formulae and product ion spectra from ForTox spectral
database to search for the presence of pseudo-molecular ions (i.e.
[M+H]+, [M+NH4]+, [M+Na]+) and possible fragment ions, show-
ing same retention time, from low (MS) and high energy (10, 20 or
40 eV) acquisition functions, respectively. A minimum of one fragment
ion was used for a tentative identification of a compound from the
ForTox database, Fig. S2. Themaximumdifference allowed form/z ratios
of ions observed in experimental spectra (recorded at low and high3
collision energies) versus those compiled in the spectral database was
20 ppm.
2.4.2. DDA analysis
In the DDA acquisition mode, spectra were recorded in the range of
m/z values from 50 to 1000. Selection of precursor ions for MS/MS ex-
periments was triggered attending to their intensities. A maximum of
5 precursors were simultaneously considered for isolation in the Q MS
analyzer and CID fragmentation. Exclusion of a given precursor was ac-
tivated after 3 MS/MS spectra (collision energies of 10, 20 and 40 eV)
were recorded. Selection of same ion was re-activated after 0.5 min.
The acquisition frequencies in MS and MS/MS modes were 4 and 8 Hz,
respectively. So, the duty cycle of the DDA operational mode was
2.13 s, versus 1 s for DIA. The DDA acquisition algorithm was applied
in the iterative mode during four consecutive injections of the same
sample, thus, precursors previously selected for MS/MS fragmentation
are excluded in further injections, within the same retention time win-
dow. This way allowed selecting up to 20 different precursor ions,
within the same retention timewindow (30 s), through the four consec-
utive injections of the same sample. Find by autoMS/MS function, also
available inMassHunter Qualitative Analysis Workflows B.08.00 software,
was used to mine spectral information from DDA records. Tentative
identifications are based on normalized spectral matches above 40%
(using both reversed and forward comparison modes) between the ex-
perimental product ion spectra and those contained in the ForTox PCDL,
at least at one of the three tested collision energies. Forward search
compares experimental spectra with those existing in the ForTox
PCDL, for the same collision energy. The reversedmode checks whether
fragment ions in the library spectrum of a given compound are present
in the experimental record. Data mining workflows following both ap-
proaches are shown in Fig. S2.
2.5. Characterization of the determination method and estimation of envi-
ronmental concentrations
The performance of the analytical methodology, including sample
preparation and determination steps, was assessed for a selection of
42 compounds, from different chemical families, confirmed in sludge
samples during screening studies. To this end, same chromatographic
conditions as those employed during screening studies were main-
tained, whilst the QTOF instrument was operated in the target MS/MS
mode (a retention timewindow of 0.5 min was set for each compound,
selecting the m/z of its precursor ion and a fixed CE). The response for
the precursor ion, obtained from MS channel, was used for quantifica-
tion purposes, whilst product ion scan spectra were employed for iden-
tity confirmation. The maximum allowed errors for retention time,
quantification and confirmation ions were 0.1 min, 10 ppm and
20 ppm, respectively.
For this selection of compounds, the extraction efficiency (EE) ofMSPD
was calculated as the ratio between the responses (peak areas without
SS correction) measured for a pool of spiked sludge samples (1 μg g−1,
referred to freeze-dried sludge) and the extracts from non-spiked frac-
tions of the same matrix fortified after finishing sample preparation,
multiplied by 100. Matrix effects (MEs) were evaluated as the difference
between the responses obtained for spiked and non-spiked extracts
from the pooled sludge matrix, divided by the response for a solvent-
based standard of the same concentration (50 ng mL−1). MEs close to
100% indicate the absence of changes between ionization yield for sludge
extracts and standard solutions (Matuszewski et al., 2003).
Concentrations existing in sludge samples were calculated using
matrix-matched standards, prepared by addition of increasing concen-
trations of selected species (4–100 ngmL−1, n=5 levels) to sludge ex-
tracts. Responses obtained for each compound (peak areas corrected
with that for the selected SS) were plotted versus the addition level
and fitted to a linear model. Semi-quantitative estimation of concentra-
tions was calculated considering the final extract volume (10 mL) and
Table 1
Retention times, quantification ions, MSPD extraction efficiency (EE) and matrix effect
(ME) for the selection of deuterated compounds. Average data for three different sludge









IMZ-d5 Pesticide 3.59 302.0870 95 ± 2 102 ± 2
CTZ-d5 Antimycotic 3.94 282.1090 96 ± 3 101 ± 1
IRB-d4 ARA IIa 4.21 433.2648 93 ± 4 95 ± 2
SER-d3 Antidepressant 4.71 309.0990 69 ± 10 101 ± 3
MCZ-d5 Antimycotic 4.72 422.0247 100 ± 4 96 ± 2
AMI-d4 Antiarrhythmic 5.18 650.0585 87 ± 5 95 ± 1
ITZ-d5 Antimycotic 5.59 710.2780 76 ± 1 96 ± 4
a ARA II, angiotensin II receptor antagonist.
Table 2
Efficiency of DDA and DIA modes for detection of selected compounds in spiked extracts
from 3 sludge samples.
Compound DDA DIA
a50 ng mL−1 a10 ng mL−1 a50 ng mL−1 a10 ng mL−1
IMZ-d5 2 3 3 3
CTZ-d5 2 3 3 0
IRB-d4 3 3 3 3
SER-d3 3 3 2 3
MCZ-d5 3 3 3 2
AMI-d4 3 3 3 3
ITZ-d5 2 0 2 0
Percentage of positive
identifications
86% 86% 90% 67%
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tion yields in the range from 70 to 120% Concentrations are reported
for 37 out of 42 identified species, after excluding those poorly recov-
ered by MSPD, presenting very high signal suppression effects, or con-
sidered as natural origin compounds.
2.6. Quality assurance and quality control measurements
Different QA/QC proceedings were implemented during the sample
preparation and analysis, in order to reduce the number of false posi-
tives and false negatives. For this purpose, the glass material was
cleaned with methanol and acetone and baked at 200 °C before its
use. In addition, one procedural blank of MSPD extraction (without
sample) was performed per batch of 5 samples, either during screening
or quantification experiments. All the samples were fortified with a
mixture of labelled-SSs and analysed in triplicate during assessment of
the analytical method performance. Semi-quantitative concentration
data were derived from duplicate analysis (extraction and determina-
tion steps) of each sludge sample. Amixture of solvent-based standards
was injected at the beginning and at the end of the sequence, in order to
evaluate the variations in the signals and also, the injection of several
solvents, to detect possible carry over contamination effects between
samples.
3. Results and discussion
3.1. Preliminary experiments
Without retention time information, the likelihood to identify a
given pollutant from its accurate spectrum in the extract from a com-
plex matrix (as it is the case of freeze-dried sludge samples) depends
on combination of factors, which are related to the employed sample
preparation conditions, the data acquisition mode, the data mining
strategy and, obviously, the spectral database of candidates. As regards
sample preparation, it is obvious that any compound not recovered
from the sludge matrix will remain undetected. However, hard extrac-
tion conditions might result in too rich extracts, whichmight lead a de-
crease of the efficiency of compounds ionization at the ESI source.
Sample preparation conditions considered in the current studywere
sludge extraction under mild conditions (room temperature and atmo-
spheric pressure) typical of the MSPD technique. No clean-up sorbent
was placed into the MSPD syringe to prevent potential losses of sludge
pollutants due to a too strong interaction with this sorbent, and MeOH
was employed as non-selective elution solvent. These conditions are
similar to those considered for extraction of organophosphate com-
pounds, with large differences among their polarities, from sludge
(Celano et al., 2014). In these preliminary experiments, the selection
of deuterated compounds reported in section 2.1 was either added to
sludge, or to MSPD extracts, in order to assess the feasibility to recover
these compounds from the spiked sludge and themagnitude ofMEs, re-
spectively. The native analogues of these compounds are moderately to
low polar species, used as pesticides or pharmaceuticals, which have
been previously determined in sludge following targeted methods
(Casado et al., 2015; Castro et al., 2016). The efficiency of MSPD extrac-
tion, corresponding to three different sludge samples spiked at 1 μg g−1,
varied between 69% to 100%, with associated standard deviations be-
tween 1 and 10%, Table 1. The assessment of MEs for spiked sludge ex-
tracts (10 mL volume) pointed out to small changes in the efficiency of
compounds ionization compared to that observed for methanol-based
standards of the same concentration (50 ng mL−1), Table 1.
The efficiency of DDA and DIA strategies to discover above com-
pounds in sludge extracts was carried out following the scheme
depicted in Fig. S2. Extracts from 3 different sludge samples, spiked at
two levels (50 and 10 ng mL−1, equivalent to sludge concentrations of
1000 and 200 ng g−1, respectively) were used. Table 2 summarizes
the number of positive identifications for each compound at both4
addition levels. Globally, DDA performed slightly better than DIA. In
the first case, false negatives were normally associated with a complex
chemical environment in the vicinity of the retention time of a given
compound, as it was the case of ITZ-d5. Under these conditions, despite
performing 4 injections of each sample, the [M+H]+ of this compound
was not within the set of 20most intense molecular features co-eluting
at same retention time; thus, it was not selected for MS/MS fragmenta-
tion. Sometimes, DDA launchedMS/MS experiments from the adduct of
ITZ-d5 with sodium, which showed a higher intensity than that of the
[M + H]+ ion. In this case, the experimental spectrum will not match
with that included in the PCDL library (recorded for the [M + H]+
ion), so the compound remains unidentified, whichmeans a false nega-
tive, Fig. S3; unless in a further iteration the sameparent ion as that used
in the PCDL database is selected by the DDA algorithm for fragmenta-
tion. A possibility to increase the number of ions submitted MS/MS ex-
periments is to raise the acquisition frequency in bothMS and auto MS/
MS modes. Unfortunately, the highest the acquisition frequency, the
lower the number of transients accumulated per spectrum, which neg-
atively affects the sensitivity of TOF MS analyzers, Fig. S4. Thus, this al-
ternative is unsuitable to detect trace compounds.
The DIA acquisition mode does not present the above commented
limitations. Usually, the isotopic pattern for the pseudo-molecular ions
of a given compound can be recognized even in a complex chemical en-
vironment as that existing at the retention time of ITZ-d5. However, for
ITZ-d5 at the lowest addition level, a false negative was again reported
systematically, Table 2. As illustrated in Fig. S5, responses for major
product ions in the PCDL spectra of this compound (PCDL spectra
were obtained from the [M + H]+ ion) remained undetected in the
high energy (40 eV) EIC chromatograms. DIA also failed to detect the
presence of CTZ-d5 in sludge extracts spiked at 10 ng mL−1. CTZ illus-
trates the behaviour of labile molecules, which are fragmented in the
ESI source. Thus, the pseudo-molecular ion ([M + H]+) represents a
minor feature compared to the major fragment corresponding, in this
case, to the loss of the imidazole ring ([M-C3H3N2]+). So, the Find by For-
mula algorithm fails to identify amolecular ion for the formula of CTZ-d5
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theDDAmodewas selected for the screening of sludge extracts for com-
pounds compiled in the ForTox PCDL.
3.2. DDA screening of pollutants in sludge
Non-target screeningwas carried out onMSPD extracts from 10 dif-
ferent sludge samples. Experimental MS/MS spectra, obtained using
DDA acquisition mode, were compared to those existing in ForTox
PCDL library. As commented in section 2.4, the minimum normalized
scores (0−100) for a tentative identificationwere set at 40, considering
forward and reversed search modes. As an example, Fig. 1 summarizes
the graphical outputs obtained during identification of the antidepres-
sant trazodone in a non-spiked sample. Fig. 1A shows the chromato-
gram corresponding to the ion submitted to MS/MS fragmentation
(extraction window 20 ppm). Points where product ion spectra were
recorded are represented by the line (spectra are just recorded at the
beginning the end and the apex of the line, at retention times of 2.657,
2.661 and 2.659 min, respectively) in Fig. 1B. The MS/MS spectra ob-
tained in these points, at three different collision energies, are depicted
in Fig. 1C. In the three cases, reverse and forward scores between these
spectra and those of trazodone in the ForTox PCDL stayed above 90 and
80 (0–100 scale); so, the compound is considered as positivelyFig. 1. Graphical information obtained from DDA data during th
5
identified. Empirical formulae for fragment ions compatible with the
empirical formula of trazodone (those highlighted in green in the
plot) are also calculated by the data mining software. Finally, a detail
of the MS spectrum at the retention time of trazodone is also shown,
Fig. 1D. In this case, the cluster of signals corresponding to the
[M+H]+ ion of this chlorinated species is evident, and the normalized
score corresponding to the fitting between the calculated and the ex-
perimentalMS spectrum of trazodone stayed around 95. However, dur-
ing mining of DDA records of sludge extracts, the fitting between
experimental and theoretical MS spectra was not considered; thus,
identifications were derived from matches between experimental MS/
MS spectra and those compiled in the ForTox database.
After excluding compounds noticed in procedural blanks, those
displaying a poor chromatographic shape (broad and/or tailing peaks),
and species showing similar scores at several retention times through
the same chromatogram, 68 compounds were identified in the set of
processed sludge samples. Table 3 compiles the list of compounds, in-
cluding their names, empirical formulae, CAS numbers, retention
times and log D value at pH 7. The number of positive samples for
each compound is also shown. The identification level was assigned ac-
cordingly to the scale proposed by Schymanski and co-workers
(Schymanski et al., 2014). Thus, code 1 corresponds to compounds
whose identity has been confirmed against authentic standards.e identification of trazodone in a non-spiked sludge sample.
Table 3
Summary of compounds identified in the extracts from 10 sludge samples using the DDA mode.
Compound Formula CAS number Retention time
(min)






Octodrine C8H19N 543–82-8 1.04 Stimulant 5 2 −0.27
Amisulpride C17H27N3O4S 71675–85-9 1.16 Antipsycotic 6 1 −0.7
O-Desmethyltramadol C15H23NO2 148262–77-5 1.18 Analgesic 3 2 n.a.
Thiabendazole C10H7N3S 148–79-8 1.47 Pesticide 4 1 2.47
Levofloxacin C18H20FN3O4 100986–85-4 1.48 Antibiotic 2 2 −0.2
Lidocaine C14H22N2O 137–58-6 1.54 Analgesic 3 2 1.36
Norharman C11H8N2 244–63-3 1.58 Alkaloid 10 1 2.03
Myosmine C9H10N2 532–12-7 1.64 Alkaloid 10 2 −2
O-Desmethylvenlafaxine C16H25NO2 142761–12-4 1.90 Antidepressant 2 1 −0.37
Tramadol C16H25NO2 27203–92-5 1.92 Analgesic 6 1 −0.6
Harman C12H10N2 486–84-0 1.94 Alkaloid 6 1 1.48
Mirtazapine C17H19N3 85650–52-8 1.95 Antidepressant 6 1 −0.05
Dextrorphan C17H23NO 125–73-5 2.03 Antitussive 6 2 1.33
Lamotrigine C9H7Cl2N5 84057–84-1 2.17 Anticonvulsant 8 1 1.23
Tapentadol C14H23NO 175591–23-8 2.28 Analgesic 10 2 0.66
8-Hydroxyquinoline C9H7NO 148–24-3 2.45 Antiseptic 10 2 0.82
Trazodone C19H22ClN5O 19794–93-5 2.61 Antidepressant 9 1 2.41
Berberine C20H18NO4 2086–83-1 2.78 Alkaloid 7 1 n.a.
Azithromycin C38H72N2O12 83905–01-5 2.81 Antibiotic 4 1 −0.06
Domperidone C22H24ClN5O2 57808–66-9 2.82 Antiemetic 1 2 2.55
Venlafaxine C17H27NO2 93413–69-5 2.84 Antidepressant 7 1 0.39
Clozapine C18H19ClN4 5786-21-0 2.94 Antipsycotic 6 1 3.23
Propranolol C16H21NO2 525–66-6 3.01 Antihypertensive 5 1 0.45
Citalopram C20H21FN2O 59729–33-8 3.06 Antidepressant 10 1 1.02
Flecainide C17H20F6N2O3 54143–55-4 3.14 Antihypertensive 9 1 0.72
Norcitalopram C19H19FN2O 62498–67-3 3.15 Antidepressant 7 1 −0.14
5-Hydroxypropafenone C21H27NO4 86384–10-3 3.19 Antiarrhythmic 4 2 0.86
Raloxifene C28H27NO4S 84449–90-1 3.21 Antitumorall 7 2 3.05
Haloperidol C21H23ClFNO2 52–86-8 3.34 Antipsycotic 2 1 2.58
Carvedilol C24H26N2O4 72956–09-3 3.41 Antihypertensive 9 1 2.69
Benzydamine C19H23N3O 642–72-8 3.47 Analgesic 4 1 1.29
Pimozide C28H29F2N3O 2062-78-4 3.49 Antipsycotic 5 2 3.99
Imazalil C14H14Cl2N2O 35554–44-0 3.58 Pesticide 6 1 3.37
Propafenone C21H27NO3 54063–53-5 3.67 Antiarrhythmic 6 1 1.02
Cyclobenzaprine C20H21N 303–53-7 3.71 Ansiolitic 4 2 4.08
Levomethadone/methadone C21H27NO 125–58-6 3.78 Analgesic 6 2 1.92
Amitriptyline C20H23N 50–48-6 3.82 Antidepressant 9 1 2.28
Chlorhexidine C22H30N10Cl2 55–56-1 3.83 Antiseptic 2 1 1.58
Ketoconazole C26H28Cl2N4O4 65277–42-1 3.84 Antimycotic 9 1 3.8
Nortriptyline C19H21N 72–69-5 3.86 Antidepressant 2 2 1.22
Clotrimazole C22H17ClN2 23593–75-1 3.93 Antimycotic 8 1 4.87
Cloperastine C20H24ClNO 3703-76-2 3.96 Antitussive 7 1 2.9
Terbutryn C10H19N5S 886–50-0 4.02 Pesticide 8 1 3.38
Fenticonazole C24H20Cl2N2OS 72479–26-6 4.04 Antimycotic 3 1 4.56
Amorolfine C21H35NO 78613–35-1 4.05 Antimycotic 6 2 5.14
Sertraline C17H17Cl2N 79617–96-2 4.05 Antidepressant 2 1 2.7
HU-331 C21H28O3 137252–25-6 4.10 Antitumoral 4 2 2.93
Telmisartan C33H30N4O2 144701–48-4 4.14 Antihypertensive 10 1 3.65
Cinnarizine C26H28N2 298–57-7 4.18 Vasodilator 5 1 4.69
Irbesartan C25H28N6O 138402–11-6 4.21 Antihypertensive 8 1 3.31
Clomipramine C19H23ClN2 303–49-1 4.22 Antidepressant 5 1 2.6
Tioconazole C16H13Cl3N2OS 65899–73-2 4.34 Antimycotic 3 1 4.11
Cyprodinil C14H15N3 121552–61-2 4.37 Pesticide 3 1 3.01
Dronedarone C31H44N2O5S 141626–36-0 4.56 Antihypertensive 5 1 5.6
Octamylamine C13H29N 502–59-0 4.74 Anticonvulsant 4 2 1.73
Miconazole C18H14Cl4N2O 22916–47-8 4.75 Antimycotic 2 1 4.81
Sertaconazole C20H15Cl3N2OS 99592–32-2 4.80 Antimycotic 8 1 5.6
Isoconazole C18H14Cl4N2O 27523–40-6 4.80 Antimycotic 5 2 4.72
Tamoxifen C26H29NO 10540–29-1 4.83 Antitumoral 4 2 3.45
Benzododecinium C21H38N 10328–35-5 4.98 Antiseptic 6 2 n. a.
Amiodarone C25H29I2NO3 1951-25-3 5.15 Antihypertensive 4 1 5.51
N-Desethylamiodarone C23H25I2NO3 83409–32-9 5.16 Antihypertensive 3 1 5.34
Desmethylclomipramine C18H21ClN2 303–48-0 5.49 Antidepressant 3 2 1.67
Ethyl hexadecyl dimethyl ammonium C20H44N 3006-10-8 5.66 Antiseptic 2 2 n.a.
Hexetidine C21H45N3 141–94-6 5.67 Antiseptic 1 2 6.07
Fenofibrate C20H21ClO4 49562–28-9 5.77 Antihypertensive 1 2 n.a.
9-Octadecenamide C18H35NO 3322-62-1 6.37 Ansiolitic 5 2 6.88
Stearamide C18H37NO 124–26-5 6.59 Plasticizer 7 2 7.29
n.a., not available.
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of product ions with those existing in the ForTox PCDL; however, their
identity was not confirmed against standards.6
Compounds in Table 3 are sorted attending to their increasing reten-
tion time. Even some polar species, considering their Log D value and
weak retention in the reversed-phase column (i.e., the antipsychotic
Fig. 2. Summary of the different families of chemicals identified in sludge, with the
normalized number of compounds per family.
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the list of compounds with retention times longer than 5 min was lim-
ited. Between 5 and 7min, chromatograms presented a high complexity
(Fig. S3A); so, only those compounds from the PCDL database showing
high intensity responses have a chance to be identified in this region. At-
tending to their uses, most compounds belong to different classes of
pharmaceuticals, alkaloids of natural sources (such as harman and
norharman), some pesticides, and active ingredients (i.e., antiseptics)
of personal care compounds and household products. As shown in
Fig. 2, above 50% of the identified species belong to three different
groups of drugs employed in chronic treatments: psychiatric drugs (in-
cluding some of their metabolites), cardiovascular and antimycotic
pharmaceuticals. Several compounds listed in Table 3 have already
been reported in the literature (Peysson and Vulliet, 2013) and also
deeply studied in sludge, such as the antibiotics (Östman et al., 2017),
the antimycotics (Castro et al., 2016; Lindberg et al., 2010) and several
cardiovascular drugs (Castro et al., 2018; Montes et al., 2015). It is
worth to mention that, several compounds included in the 3rd revision
of the EU watch list of water pollutants (i.e., imazalil, clotrimazole, mi-
conazole, venlafaxine and its O-demethylated form) were identified in
sludge using the non-target DDA mode. Other species included in
Table 3, such as levomethadone/methadone, amiodarone, lamotrigine,
raloxifene, cyclobenzaprine, trazodone and chlorhexidine are included
in the list of high production volume pharmaceuticals (Howard and
Muir, 2011). To the best of our knowledge, pharmaceuticals as carve-
dilol, cinnarizine, cyclobenzaprine, dextorphan, octamylamine and ral-
oxifene; and the fungicides amorolfine and hexetidine, are reported in
sludge for the first time.
3.3. Characterization of the analytical methodology
The performance of sample preparation and determination condi-
tions were evaluated for those compounds in Table 3, whose identity
was confirmed with standards (attending to their availability and bud-
get limitations), in terms of EEs and MEs. Out of 42 identified com-
pounds, chlorhexidine and 8-hydroxyquinoline showed poor
extraction yield (c.a. 25%), and low ionization efficiency in MSPD ex-
tracts (signal suppression around 80%), respectively. Data for the rest
of compounds are compiled in Table 4. In addition to EEs and MEs, de-
termination coefficients (R2) obtained for spiked sludge extracts
(concentration range 0–100 ng mL−1, n = 5 levels), instrumental and
procedural limits of quantification (LOQs) are provided. Instrumental
LOQs are defined as the lowest concentration for a solvent-based stan-
dard providing a signal to noise ratio of 10 for the quantification ion.7
Procedural LOQs were calculated from instrumental LOQs multiplied
by EEs andMEs, when they remained below 80%. Overall, the EEs varied
from 79 to 123%, with relative standard deviations below 17%. MEs
ranged between 51 and 135% with SD below 12%, depending on the
compound. The obtained LOQs varied from 0.3 ng g−1 to 45 ng g−1 for
amitriptyline and haloperidol, respectively.
3.4. Semi-quantitative determination of emerging pollutants
Compound residues were estimated in a set of samples obtained
from 16 STPs, Fig. S1. Samples were processed in four batches with a
procedural blank per sample. Concentrations referred to freeze dried
sludge, assuming identical MEs for every sample, are shown as supple-
mentary information, Table S1. Table S1 compiles also their detection
frequencies, median, minimum and maximum concentrations levels.
Table S1 includes those compounds for which method performance
was previously assessed (Table 4), excluding 3 species which might
have a natural origin (harman, norharman and berberine). Thus, 20
out of the 37 compounds in this table were found in at least the 80%
of the studied samples, with median concentrations between 5 and up
to 2000 ng g−1. Fig. 3 shows the sum of their concentrations in each
sample, the number of compounds above LOQs and the highest concen-
tration species. The total residue for the set of 37 compounds in sludge
varied from 1.4 to more than 15 μg g−1, being telmisartan the pollutant
displaying the highest concentrations in 12 out of 16 sludge samples.
From data summarized in Table S1, 13 species presented median con-
centrations above 100 ng g−1, and 10 of thesemicropollutants were no-
ticed in more than 50% of the processed samples. Fig. 4 presents the
normalized contribution of each of these compounds to the total residue
found in each sample, being all of them employed as pharmaceuticals.
O-desmethylvenlafaxine is not only an authorized antidepressant, but
also one of the main metabolites of venlafaxine. The median residues
of the O-desmethylated species were higher than those found for
venlafaxine, which agrees with their relative levels in raw wastewater
(González-Mariño et al., 2018). Moreover, except for sample code 8,
the sum of concentrations for compounds compiled in Fig. 4 represents
more than 50% of total residues measured in these samples (Table S1).
The odd pattern observed for sludge code 8 is due to the presence of a
very high residue of cinnarizine (above 8000 ng g−1 compared with a
median value of 40 ng g−1 in the set of processed samples). Among
others, cinnarizine is used in anti-motion sickness preparations; thus,
an accidental or intentional direct disposal of the compound in the net
of sewers cannot be excluded. It is worth noting that compounds with
the highest concentrations, such as the antidepressants, sertraline and
O-desmethylvenlafaxine; the antimycotics ketoconazole, miconazole
and clotrimazole; and the antihypertensive, telmisartan are highly con-
sumed drugs in Spain, with 9 daily diary doses (DDD) per 1000 inhabi-
tants for sertraline in year 2014; 0.3 DDD for antimycotics and 3.4 DDD
for telmisartan in 2018 (“Agencia española del medicamento y
productos sanitarios (AEMPS),”, n.d.). In addition to their high con-
sumption, the Log D of these substances, at neutral pH, points out to
very low polarity (4.2–6.13), thus the absorption in the sludge is highly
favoured, which, combined with a limited biodegradation, explains the
high concentrations in this type of samples. In case of species found at
relevant concentrations in the water phase of STPs, as it is the case of
sertraline, O-desmethylvenlafaxine, cloperastine and amitriptyline
(Skees et al., 2018), their partial accumulation in sludge need to be
kept in mind to calculate their removal efficiencies during wastewater
treatment.
4. Conclusions
The combination of soft extraction conditions employed in MSPD
with UPLC-ESI-QTOF-MS permitted the non-target identification of
more than 60 micropollutants in sludge from municipal STPs. During
preliminary method development, it has been demonstrated that both
Table 4
Analytical features of the determination method for a mixture of model compounds.
Compound SS [M + H]+ CE (eV) Product ion Linearity (R2,
0–100 ng mL-1)




O-Desmethyl venlafaxine SER-d3 264.1958 20 58.0650 0.9999 112 ± 6 111 ± 6 0.7 14.5
Mirtazapine SER-d3 266.1652 20 195.0924; 72.0810 0.9926 112 ± 3 83 ± 3 0.1 1.8
Venlafaxine SER-d3 278.2115 20 58.0651; 121.0648 0.9967 110 ± 3 89 ± 1 0.1 2.3
Sertraline SER-d3 306.0811 20 158.9765; 275.0389 0.9987 98 ± 2 114 ± 1 0.8 15.0
Norcitalopram SER-d3 311.1554 20 262.1035; 109.0448 0.9979 106 ± 5 114 ± 1 0.7 14.3
Citalopram SER-d3 325.1711 20 262.1026; 109.0448 0.9988 104 ± 5 100 ± 4 0.2 4.5
Clozapine SER-d3 327.1371 20 270.0792 0.9941 107 ± 6 101 ± 1 0.3 6.8
Amisulpride SER-d3 370.1795 20 242.0487 0.9988 98 ± 6 94 ± 3 0.2 3.1
Trazodone SER-d3 372.1586 20 176.0823 0.9984 123 ± 6 88 ± 4 0.2 3.1
Thiabendazole IMZ-d5 202.0433 40 175.0324; 131.0604 0.9959 116 ± 10 83 ± 5 0.5 10.9
Cyprodinil IMZ-d5 226.1339 40 93.0573 0.9961 80 ± 9 74 ± 8 0.5 13.5
Terbutryn IMZ-d5 242.1434 20 186.0808 0.9926 111 ± 8 90 ± 3 1.1 22.1
Clotrimazole CTZ-d5 277.0785 20 242.1090; 165.0698 0.9843 108 ± 8 73 ± 4 0.1 3.1
Imazalil IMZ-d5 297.0556 20 255.0086; 158.9763 0.9942 120 ± 9 86 ± 8 0.2 3.9
Tioconazole CTZ-d5 386.9887 20 130.9719 0.9998 86 ± 11 51 ± 7 0.2 7.5
Miconazole MCZ-d5 416.9900 20 158.8746 0.9988 96 ± 6 78 ± 5 0.4 11.4
Sertaconazole CTZ-d5 437.0043 20 180.9873 0.9868 99 ± 2 74 ± 1 0.4 10.8
Fenticonazole CTZ-d5 455.0746 20 199.0576 0.9966 115 ± 11 80 ± 7 0.6 16.6
Ketoconazole CTZ-d5 531.156 40 489.1455; 82.0625 0.9996 112 ± 11 78 ± 1 0.2 6.9
Norharman IRB-d4 169.0760 40 115.0543 0.9870 118 ± 11 85 ± 4 0.02 0.5
Harman IRB-d4 183.0917 40 115.0544 0.9940 113 ± 9 77 ± 3 0.02 0.6
Propranolol IRB-d4 260.1645 20 183.0804; 116.1069 0.9967 113 ± 12 96 ± 5 0.31 6.1
Cloperastine IRB-d4 330.1619 20 201.0465; 166.0777 0.9976 114 ± 10 84 ± 4 0.32 6.3
Flecainide IRB-d4 415.1451 40 301.0294 0.9989 119 ± 12 95 ± 12 0.02 0.5
Irbesartan IRB-d4 429.2397 20 207.0917 0.9975 98 ± 4 104 ± 4 0.27 5.4
Telmisartan IRB-d4 515.2442 40 497.2336; 276.1396 0.9993 (0−2000) 81 ± 13 74 ± 3 0.13 4.7
Dronedarone AMI-d4 557.3044 40 435.2676; 142.1596 0.9834 87 ± 5 81 ± 5 0.56 11.2
N-Desethylamiodarone AMI-d4 617.9997 20 546.9261; 72.0807 0.9870 106 ± 17 85 ± 4 0.02 0.5
Amiodarone AMI-d4 646.0310 40 201.0910; 100.1121 0.9989 112 ± 77 67 ± 2 0.02 0.6
Azithromycin IRB-d4 749.5158 40 591.4215; 158.1175 0.9919 123 ± 12 135 ± 3 0.04 0.8
Lamotrigine SER-d3 256.0151 40 210.9824; 144.9606 0.9959 103 ± 8 57 ± 2 0.01 0.4
Tramadol SER-d3 264.1958 20 58.0651 0.9958 103 ± 5 98 ± 2 0.46 9.2
Amitriptyline SER-d3 278.1903 20 233.1325; 91.0542 0.9917 95 ± 8 82 ± 1 0.014 0.3
Benzydamine SER-d3 310.1914 20 86.0964; 58.0650 0.9901 95 ± 8 87 ± 2 0.20 4.0
Clomipramine SER-d3 315.1623 20 86.0964; 58.0650 0.9971 79 ± 5 80 ± 2 0.68 13.6
Berberine SER-d3 336.1235 40 320.0917; 292.0968 0.9840 95 ± 10 90 ± 2 0.02 0.4
Propafenone SER-d3 342.2064 20 116.1069; 72.0807 0.9957 101 ± 6 93 ± 1 0.17 3.5
Cinnarizine SER-d3 369.2325 20 167.0856 0.9984 84 ± 4 85 ± 1 0.97 19.3
Haloperidol SER-d3 376.1474 20 165.0708; 1123.0241 0.9932 100 ± 10 60 ± 2 1.35 45.0
Carvedilol SER-d3 407.1965 20 224.1281; 100.0757 0.9993 100 ± 14 103 ± 3 0.39 7.9
G. Castro, M. Ramil, R. Cela et al. Science of the Total Environment 778 (2021) 146256non-target acquisition modes considered in the current study were
prone to report false negatives, particularly when compounds elute in
chromatographic regions with a high number of molecular features
and/or when they do not lead to formation of pseudomolecular ions
during ESI ionization. Keeping in mind these limitations, when used inFig. 3. Total concentration, concentration of the most abundant pollutant a
8
the iterative mode, DDA was found to perform slightly better than
DIA. Most of the compounds identified in the study are pharmaceuticals
or their human excretion metabolites. The obtained semi-quantitative
concentration values highlighted a group of 10 compounds combining
high detection frequencies and median concentrations abovend number of compounds above LOQ in sludge extracts from 16 STPs.
Fig. 4. Normalized concentrations of compounds showing median values above 100 ng g−1 and detection frequencies higher than 50% in the set of sludge samples from 16 STPs.
G. Castro, M. Ramil, R. Cela et al. Science of the Total Environment 778 (2021) 146256100 ng g−1. Some of these compounds (O-desmethylvenlafaxine and
the antimycotic drugs: miconazole, clotrimazole and ketoconazole)
are concerning species, which have been included in the recent revision
of the watch list of pollutants to be monitored in the aquatic environ-
ment based on their potential chronic toxicities. Thus, the analysis of
sludge from STPs is mandatory to obtain an integrated overview of
their mass balances during municipal sewage treatments.
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